CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

Home About What We Do Programs and Services CADTH Reimbursement Review Sodium oxybate

Sodium oxybate

Last Updated: August 29, 2007

Result type: Reports

Project Number: SR0107-000

Product Line: Reimbursement Review

Generic Name: Sodium oxybate

Brand Name: Xyrem

Manufacturer: Valeant Canada Ltd.

Therapeutic Area: Narcolepsy

Indications: Narcolepsy

Submission Type: Initial

Project Status: Withdrawn

Sodium oxybate

Files